NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
Sold this one for a 3.70% gain after weakness on earnings.
The story seems intact. Good risk/reward entry here at 50 days line again.
IBD rating 98
RS rating 92
Long @ 620.37.

Keep it simple: price action and volume
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.